О себе
Claes Gustafsson is a Swedish physician-scientist and professor of medical biochemistry at the University of Gothenburg, where he leads research on mitochondrial gene expression and mitochondrial molecular genetics. He is a co-founder of Pretzel Therapeutics, a biotech company developing therapies that modulate mitochondrial function. Public sources position him primarily as a scientific founder and academic expert in mitochondrial biology rather than as a capital allocator.
Области интересов
biotechmitochondrial biologymitochondrial gene expressionmedical biochemistrysynthetic biologybiologics manufacturingdrug developmentgenome engineering